JPH0318602B2 - - Google Patents

Info

Publication number
JPH0318602B2
JPH0318602B2 JP57223103A JP22310382A JPH0318602B2 JP H0318602 B2 JPH0318602 B2 JP H0318602B2 JP 57223103 A JP57223103 A JP 57223103A JP 22310382 A JP22310382 A JP 22310382A JP H0318602 B2 JPH0318602 B2 JP H0318602B2
Authority
JP
Japan
Prior art keywords
deferoxamine
patients
disease
aluminum
alzheimer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57223103A
Other languages
English (en)
Japanese (ja)
Other versions
JPS58121213A (ja
Inventor
Reimondo Makurakuran Donarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS58121213A publication Critical patent/JPS58121213A/ja
Publication of JPH0318602B2 publication Critical patent/JPH0318602B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP57223103A 1981-12-21 1982-12-21 アルツハイマ−病治療剤 Granted JPS58121213A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US332794 1981-12-21
US06/332,794 US4419365A (en) 1981-12-21 1981-12-21 Method of treating Alzheimer's disease

Publications (2)

Publication Number Publication Date
JPS58121213A JPS58121213A (ja) 1983-07-19
JPH0318602B2 true JPH0318602B2 (enExample) 1991-03-13

Family

ID=54774394

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57223103A Granted JPS58121213A (ja) 1981-12-21 1982-12-21 アルツハイマ−病治療剤

Country Status (6)

Country Link
US (1) US4419365A (enExample)
JP (1) JPS58121213A (enExample)
BE (1) BE895406A (enExample)
DE (1) DE3247062A1 (enExample)
IT (1) IT1155241B (enExample)
ZA (1) ZA829335B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912118A (en) * 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
USRE34313E (en) * 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
US5177068A (en) * 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
KR870700065A (ko) * 1984-12-19 1987-02-28 아놀드 자일러, 에른스트 알테르 신규한 카본산 에스테르
US5217998A (en) * 1985-07-02 1993-06-08 Biomedical Frontiers, Inc. Composition for the stabilization of deferoxamine to chelate free ions in physiological fluid
EP0214101A3 (de) * 1985-09-03 1989-05-31 Ciba-Geigy Ag Verwendung von Eisen(III)-Chelatoren vom Typ Desferrioxamin B und Desferriferrithiocin zur Behandlung von Malaria
US4599361A (en) * 1985-09-10 1986-07-08 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4698431A (en) * 1985-11-12 1987-10-06 The United States Of America As Represented By The United States Department Of Energy Hydroxypyridonate chelating agents
US5707604A (en) * 1986-11-18 1998-01-13 Access Pharmaceuticals, Inc. Vivo agents comprising metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles
US5672334A (en) * 1991-01-16 1997-09-30 Access Pharmaceuticals, Inc. Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
US4897388A (en) * 1988-12-20 1990-01-30 Geriatric Research Institute, Inc. Method of treating Alzheimer's disease
US5023784A (en) * 1989-04-06 1991-06-11 Doral Technical Services, Inc. Method for diagnosing serum deficiencies
US5158979A (en) * 1989-04-19 1992-10-27 New York University Method and compositions for treating pneumocystic carini infections
US5268165A (en) * 1990-10-16 1993-12-07 Biomedical Frontiers, Inc. Polymer-deferoxamine-ferric iron adducts for use in magnetic resonance imaging
CA2123211C (en) * 1991-11-12 2008-09-16 Colin L. Masters A method for assaying and treating alzheimer's disease
HU214452B (hu) * 1992-06-01 1998-03-30 BIOGAL Gyógyszergyár Rt. Eljárás nagytisztaságú deferoxamin-B-sók előállítására
GB9211779D0 (en) * 1992-06-03 1992-07-15 Ciba Geigy Ag Amine salts
TW274630B (enExample) * 1994-01-28 1996-04-21 Wako Zunyaku Kogyo Kk
JPH0925234A (ja) * 1995-07-12 1997-01-28 Wakunaga Pharmaceut Co Ltd 脳疾患改善剤
US6106866A (en) * 1995-07-31 2000-08-22 Access Pharmaceuticals, Inc. In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites
BR9813465A (pt) 1997-12-09 2002-01-22 Biomed Frontiers Inc Polissacarìdeos modificados que exibem reconhecimento biológico alterado
US20030236224A1 (en) * 1997-12-09 2003-12-25 Hedlund Bo E. Modified polysaccharides exhibiting altered biological recognition
US6780852B2 (en) 1997-12-09 2004-08-24 Bo E. Hedlund Modified polysaccharides exhibiting altered biological recognition
US7189703B2 (en) * 1998-01-09 2007-03-13 Intracell, Llc Treatment and diagnosis of alzheimer's disease
US6638711B1 (en) 1999-04-29 2003-10-28 The General Hospital Corporation Methods for identifying an agent that inhibits oxygen-dependent hydrogen peroxide formation activity but does not inhibit superoxide-dependent hydrogen peroxide formation
US20050112543A1 (en) * 1998-03-11 2005-05-26 The General Hospital Corporation Method of screening for drugs useful in treating Alzheimer's disease
US6506740B1 (en) 1998-11-18 2003-01-14 Robert A. Ashley 4-dedimethylaminotetracycline derivatives
US6946453B2 (en) 1998-11-18 2005-09-20 Collagenex Pharmaceuticals, Inc. 4-dedimethylaminotracycline derivatives
DE10222561B4 (de) 2002-05-17 2009-12-10 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
US7728038B2 (en) * 2004-08-04 2010-06-01 University Of Utah Research Foundation Methods for chelation therapy
PL3300742T3 (pl) 2014-07-11 2021-05-04 Grifols Worldwide Operations Limited Transferryna do stosowania w leczeniu zaburzeń związanych z czynnikiem indukowanym hipoksją (HIF) takich jak niedokrwienie
CN112972490B (zh) * 2021-03-04 2022-02-18 中国人民解放军军事科学院军事医学研究院 透明质酸在用于制备预防或治疗铁死亡相关疾病的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1898E (fr) 1903-04-01 1903-11-07 Louis Galland Concasseur à machoires multiples
DE1123436B (de) 1959-09-25 1962-02-08 Ciba Geigy Verfahren zur Herstellung neuer Wuchsstoffe
FR1315046A (fr) 1960-10-11 1963-01-18 Ciba Geigy Procédé de préparation d'acides trihydroxamiques à longue chaîne et de leurs composés complexes
FR1315047A (fr) 1960-10-11 1963-01-18 Ciba Geigy Procédé de préparation d'acides trihydroxamiques à longue chaîne

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS *
CHMICAL ABSTRACTS *

Also Published As

Publication number Publication date
IT8249698A0 (it) 1982-12-20
IT1155241B (it) 1987-01-21
DE3247062C2 (enExample) 1993-07-01
BE895406A (fr) 1983-06-20
US4419365A (en) 1983-12-06
DE3247062A1 (de) 1983-07-07
JPS58121213A (ja) 1983-07-19
IT8249698A1 (it) 1984-06-20
ZA829335B (en) 1983-09-28

Similar Documents

Publication Publication Date Title
JPH0318602B2 (enExample)
Udaka et al. Pathologic laughing and crying treated with levodopa
Berger et al. The cholinergic rapid eye movement sleep induction test with RS-86: State or trait marker of depression?
De Kruijk et al. Diagnostic criteria and differential diagnosis of mild traumatic brain injury
Baron et al. Lithium carbonate response in depression: prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history
Bartolini et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study
Carroll et al. Alpha and beta coma in drug intoxication uncomplicated by cerebral hypoxia
AU2023208107B2 (en) Composition comprising an anti-Αβ protofibril antibody and a beta- secretase BACE1 inhibitor for the treatment of Alzheimer's disease
US12337006B1 (en) Methods of treating ischemic stroke at risk for cerebral or cerebellar edema
US12251388B1 (en) Methods of treating ischemic stroke at risk for cerebral or cerebellar edema
Pollock et al. Topographic quantitative EEG amplitude in recovered alcoholics
MX2012001814A (es) Uso de 4-aminopiridina para mejorar la discapacidad neuro - cognoscitiva y/o neuro - psiquiatrica en pacientes con condiciones desmielizantes y otras condiciones del sistema nervioso.
Haldeman et al. Progressive supranuclear palsy, computed tomography, and response to antiparkinsonian drugs
Kristensen et al. Levodopa treatment of presenile dementia
Kline et al. Non-convulsive status epilepticus in a patient with hypocalcemia
KR20170120708A (ko) 탈수초를 갖는 환자에서 ４-아미노피리딘을 사용한 지속적 치료
Saletu et al. Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life
Cohen et al. Grand mal seizure in a postpartum patient following intravenous infusion of caffeine sodium benzoate to treat persistent headache
Levy Pharmacological treatment of aged patients in a state mental hospital
Wang et al. Determination of the ED50 and ED95 of intravenous bolus of norepinephrine for the treatment of hypotension during spinal anesthesia for cesarean delivery
Schittecatte et al. Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness
Buchhalter et al. Effects of valproic acid in cultured mammalian neurons
EP1535616A1 (en) Remedy for integration dysfunction syndrome
JP2965949B2 (ja) アルツハイマー型老人性痴呆症検出用組成物
GIBBS Electroencephalography